Student pricing is available for eligible university email holders. View plans

NextSprints
NextSprints Icon NextSprints Logo
Product Design

Master the art of designing products

Product Improvement

Identify scope for excellence

Product Success Metrics

Learn how to define success of product

Product Root Cause Analysis

Ace root cause problem solving

Product Trade-Off

Navigate trade-offs decisions like a pro

All Questions

Explore all questions

Meta (Facebook) PM Interview Course

Practice Meta-focused PM cases

Amazon PM Interview Course

Practice Amazon-focused PM cases

Apple PM Interview Course

Practice Apple-focused PM cases

Google PM Interview Course

Practice Google-focused PM cases

Microsoft PM Interview Course

Practice Microsoft-focused PM cases

All Courses

Explore all courses

1:1 PM Coaching

Practice in a one-to-one session

Resume Review

Narrate impactful stories via resume

Guides Pricing
nextsprints logo

Not a member?

By proceeding, you agree to our Terms of Use and confirm you have read our Privacy and Cookie Statement.

nextsprints logo

Register to continue.

Login with Google Login with LinkedIn

By proceeding, you agree to our Terms of Use and confirm you have read our Privacy and Cookie Statement .

Company focus

Kenvue
Product Trade-Off Hard Member-only

Should Kenvue prioritize expanding its Tylenol product line or focus on improving existing formulations to enhance efficacy?

Prepared by NextSprints

15 mins
Report an error
Strategic Decision Making Market Analysis Product Development Pharmaceuticals Consumer Health Over-the-Counter Medications Product Strategy Product Improvement Market Expansion Trade-Off Analysis Pharmaceutical Industry
Product Management Trade-Off Question: Kenvue Tylenol expansion versus efficacy improvement strategy

Introduction

The trade-off we're examining today is whether Kenvue should prioritize expanding its Tylenol product line or focus on improving existing formulations to enhance efficacy. This decision involves balancing potential market growth against product quality improvements. I'll analyze this trade-off by considering market dynamics, consumer needs, and Kenvue's strategic objectives.

Analysis Approach

I'll start by asking clarifying questions, then identify the trade-off type, analyze the product, and develop a hypothesis. From there, I'll define key metrics, design an experiment, plan data analysis, create a decision framework, and finally provide a recommendation with next steps.

Step 1

Clarifying Questions (3 minutes)

  • Context: I'm thinking about Tylenol's current market position. Could you share Tylenol's current market share and growth rate in the OTC pain relief category?

Why it matters: Helps assess the urgency of expansion vs. improvement Expected answer: Stable market leader with moderate growth Impact: Low growth might favor efficacy improvements, high growth could support expansion

  • Business Context: Based on industry trends, I'm considering if there's a shift towards more specialized pain relief products. How does Kenvue view the balance between general and targeted pain relief in its portfolio strategy?

Why it matters: Informs whether to expand into niche markets or enhance core products Expected answer: Growing interest in targeted solutions Impact: Would lean towards expansion if confirmed

  • User Impact: Considering changing consumer behaviors, I'm curious about recent shifts in how consumers choose OTC pain relievers. Have you noticed any significant changes in purchase drivers or brand loyalty?

Why it matters: Helps prioritize efficacy vs. variety in product strategy Expected answer: Increasing emphasis on effectiveness and natural ingredients Impact: Strong efficacy focus would support improving existing formulations

  • Technical: Thinking about Tylenol's formulation, I'm wondering about the current state of R&D. Are there any promising new compounds or delivery methods in the pipeline that could significantly enhance efficacy?

Why it matters: Assesses potential for meaningful improvements in existing products Expected answer: Some advancements, but nothing revolutionary Impact: Limited potential might favor expansion strategy

  • Resource: Considering the scale of either option, I'm thinking about resource allocation. What's the current split of R&D budget between new product development and improving existing formulations?

Why it matters: Indicates organizational readiness for either strategy Expected answer: 60/40 split favoring new product development Impact: Might need to realign resources based on chosen strategy

Subscribe to access the full answer

Image of author NextSprints

NextSprints

Updated Jan 22, 2025